Last Updated: June 22, 2026

DEXMETHYLPHENIDATE Drug Patent Profile

Name: DEXMETHYLPHENIDATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Dexmethylphenidate patents expire, and when can generic versions of Dexmethylphenidate launch?

Dexmethylphenidate is a drug marketed by Adare Pharms Inc, Ascent Pharms Inc, Aurolife Pharma Llc, Granules, Impax Labs Inc, Ph Health, Platinum, Sun Pharm Inds Inc, Teva Pharms Usa, Abhai Llc, Alkem Labs Ltd, Bionpharma, Cediprof Inc, Lannett Co Inc, Novel Labs Inc, Rhodes Pharms, Sun Pharm Industries, Teva Pharms, and Tris Pharma Inc. and is included in twenty-one NDAs.

The generic ingredient in DEXMETHYLPHENIDATE is dexmethylphenidate hydrochloride. There are six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dexmethylphenidate hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dexmethylphenidate

A generic version of DEXMETHYLPHENIDATE was approved as dexmethylphenidate hydrochloride by PLATINUM on November 18^th, 2013.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DEXMETHYLPHENIDATE?
What are the global sales for DEXMETHYLPHENIDATE?
What is Average Wholesale Price for DEXMETHYLPHENIDATE?

Summary for DEXMETHYLPHENIDATE

US Patents:	0
Applicants:	19
NDAs:	21
Drug Prices:	Drug price information for DEXMETHYLPHENIDATE
DailyMed Link:	DEXMETHYLPHENIDATE at DailyMed

Drug patent expirations by year for DEXMETHYLPHENIDATE

US Patents and Regulatory Information for DEXMETHYLPHENIDATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abhai Llc	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	TABLET;ORAL	206931-003	Dec 4, 2015	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ph Health	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	202842-002	Nov 30, 2016	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Granules	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	213813-008	Sep 9, 2020	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Rhodes Pharms	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	TABLET;ORAL	208756-001	Nov 20, 2017		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Platinum	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	078992-002	Nov 23, 2021	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for DEXMETHYLPHENIDATE

Dexmethylphenidate hcl brand name?
Dexmethylphenidate er price?
Side effects of dexmethylphenidate?
Dexmethylphenidate brand name?
Dexmethylphenidate er brand name?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.